QSAR study of phenoxypyrimidine derivatives as potent inhibitors of p38 kinase using different chemometric tools

16Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Selective inhibition of the CSBP/p38 mitogen-activated protein kinase pathway may be an attractive target for the development of therapeutic agents to treat chronic inflammatory disease. A series of Phenoxypyrimidine Derivatives as Potent Inhibitors of p38 Kinase was subjected to quantitative structure-activity relationship (QSAR) analysis to find the structural requirements for ligand binding. A collection of chemometrics methods including multiple linear regression (MLR), factor analysis-based multiple linear regression (FA-MLR), principal component regression and partial least squared combined with genetic algorithm for variable selection (GA-PLS) were employed to make connections between structural parameters and enzyme inhibition. The results revealed the significant roles of steric effect, hydrogen bonding and electronic properties on the p38 inhibitory activity of the studied molecules. The most significant QSAR model, obtained by GA-PLS, could explain and predict 98% and 87% of variances in the pIC50 data, respectively. © 2007 The Authors.

Cite

CITATION STYLE

APA

Edraki, N., Hemmateenejad, B., Miri, R., & Khoshneviszade, M. (2007). QSAR study of phenoxypyrimidine derivatives as potent inhibitors of p38 kinase using different chemometric tools. Chemical Biology and Drug Design, 70(6), 530–539. https://doi.org/10.1111/j.1747-0285.2007.00597.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free